A Phase III Trial Evaluating the Role of Ovarian Function Suppression and the Role of Exemestane as Adjuvant Therapies for Premenopausal Women with Endocrine Responsive Breast Cancer (Suppression of Ovarian Function-“ SOFT”)

  • White, Michelle (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

HREC ref: 04181A
StatusActive
Effective start/end date8/02/19 → 7/02/24